Adherence to recommendations for clinical follow-up after benign breast biopsy

Citation
Ma. Andrykowski et al., Adherence to recommendations for clinical follow-up after benign breast biopsy, BREAST CANC, 69(2), 2001, pp. 165-178
Citations number
63
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BREAST CANCER RESEARCH AND TREATMENT
ISSN journal
01676806 → ACNP
Volume
69
Issue
2
Year of publication
2001
Pages
165 - 178
Database
ISI
SICI code
0167-6806(2001)69:2<165:ATRFCF>2.0.ZU;2-F
Abstract
Purpose. Women who undergo a benign breast biopsy are at elevated risk for the subsequent development of breast cancer (BC). Therefore, appropriate cl inical follow-up of a benign breast biopsy is important. The present study examines the extent and correlates of nonadherence with follow-up recommend ations after a benign breast biopsy. Methods. Women (n = 114) who had undergone a benign breast biopsy completed an initial telephone interview within 50 days of their biopsy (mean = 21 d ays). Additional telephone interviews were completed at 4 and 8 months post -biopsy. Measures of BC risk perception, general and BC-specific distress, BC-related attitudes and beliefs, social support, optimism, and information al coping style were completed. Specific recommendations for clinical follo w-up and evidence of actual follow-up were obtained from medical records. Results. Of 103 women given a specific recommendation for clinical follow-u p, 34% were classified as nonadherent with follow-up recommendations. Logis tic regression analyses indicated that nonadherent women were characterized by younger age, recommendations for follow-up by clinical breast examinati on alone, greater confidence in their ability to perform breast self-examin ation properly, higher perceived personal risk for BC, and greater BC-speci fic distress. Conclusion. Despite the importance of appropriate clinical follow-up of a b enign breast biopsy, about one-third of women did not adhere to recommended follow-up. Risk factors for nonadherence suggest potential avenues for int erventions to enhance participation in appropriate clinical follow-up.